BUILDING A LEADING ONCOLOGY FRANCHISE

DIFFERENTIATED CANDIDATES ADDRESSING CLEAR NEEDS

STRONG FINANCIALS, OPTIMALLY BUILDING VALUE

View our 2018 annual report.

Latest News

MEI Pharma Announces Updated Clinical Data from ME-401 Phase 1b Study in Patients with Indolent B-cell Malignancies
MEI Pharma to Host Investor and Analyst Event on October 4, 2019
MEI Pharma to Present at the 2019 Wells Fargo Healthcare Conference
MEI Pharma Reports Fiscal Year 2019 Results and Operational Highlights